 Henry Galan
Concepts (492)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 48 | 2023 | 468 | 7.430 |
Why?
| | Ultrasonography, Prenatal | 35 | 2023 | 236 | 4.360 |
Why?
| | Placenta | 27 | 2022 | 628 | 2.960 |
Why?
| | Ultrasonography, Doppler | 18 | 2023 | 105 | 2.740 |
Why?
| | Pregnancy | 100 | 2023 | 5520 | 2.680 |
Why?
| | Umbilical Arteries | 12 | 2023 | 41 | 2.500 |
Why?
| | Gestational Age | 35 | 2023 | 760 | 1.910 |
Why?
| | Gynecology | 4 | 2022 | 163 | 1.570 |
Why?
| | Uterine Artery | 6 | 2020 | 67 | 1.570 |
Why?
| | Fetus | 23 | 2023 | 700 | 1.540 |
Why?
| | Meningomyelocele | 5 | 2022 | 55 | 1.320 |
Why?
| | Sheep | 25 | 2017 | 764 | 1.310 |
Why?
| | Fetal Weight | 7 | 2022 | 52 | 1.230 |
Why?
| | Pregnancy, Twin | 4 | 2022 | 17 | 1.220 |
Why?
| | Obstetrics | 6 | 2022 | 146 | 1.130 |
Why?
| | Fetofetal Transfusion | 4 | 2022 | 21 | 1.080 |
Why?
| | Fetal Diseases | 5 | 2017 | 147 | 1.030 |
Why?
| | Fetal Development | 3 | 2021 | 248 | 1.000 |
Why?
| | Infant, Small for Gestational Age | 7 | 2022 | 76 | 0.990 |
Why?
| | Female | 105 | 2023 | 59573 | 0.980 |
Why?
| | Infant, Newborn | 33 | 2023 | 5048 | 0.950 |
Why?
| | Inositol | 5 | 2014 | 23 | 0.880 |
Why?
| | Delivery, Obstetric | 5 | 2021 | 118 | 0.850 |
Why?
| | Sorbitol | 4 | 2014 | 15 | 0.780 |
Why?
| | Nitric Oxide Synthase Type III | 6 | 2011 | 184 | 0.780 |
Why?
| | Umbilical Veins | 6 | 2009 | 58 | 0.730 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 104 | 0.710 |
Why?
| | Cerclage, Cervical | 2 | 2022 | 4 | 0.710 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 2 | 2010 | 12 | 0.660 |
Why?
| | Altitude | 4 | 2013 | 432 | 0.660 |
Why?
| | Uterine Cervical Incompetence | 1 | 2019 | 2 | 0.660 |
Why?
| | Pregnancy Outcome | 9 | 2020 | 337 | 0.630 |
Why?
| | Birth Weight | 9 | 2021 | 440 | 0.620 |
Why?
| | Pregnancy, Animal | 4 | 2012 | 52 | 0.620 |
Why?
| | Pre-Eclampsia | 4 | 2015 | 165 | 0.620 |
Why?
| | Internship and Residency | 3 | 2022 | 926 | 0.580 |
Why?
| | Pregnancy Complications | 6 | 2023 | 429 | 0.580 |
Why?
| | Humans | 87 | 2023 | 114711 | 0.570 |
Why?
| | Placental Insufficiency | 6 | 2017 | 102 | 0.560 |
Why?
| | Bradycardia | 1 | 2017 | 48 | 0.550 |
Why?
| | Atrioventricular Block | 1 | 2017 | 37 | 0.550 |
Why?
| | Regional Blood Flow | 7 | 2011 | 424 | 0.540 |
Why?
| | Blood Flow Velocity | 7 | 2022 | 387 | 0.530 |
Why?
| | Laser Coagulation | 1 | 2016 | 54 | 0.510 |
Why?
| | Maternal-Fetal Exchange | 8 | 2021 | 151 | 0.510 |
Why?
| | Body Composition | 5 | 2022 | 590 | 0.510 |
Why?
| | Hernias, Diaphragmatic, Congenital | 3 | 2023 | 186 | 0.500 |
Why?
| | Adipose Tissue | 3 | 2016 | 545 | 0.490 |
Why?
| | Disease Models, Animal | 14 | 2021 | 3535 | 0.470 |
Why?
| | Uterus | 3 | 2011 | 192 | 0.470 |
Why?
| | Amino Acids | 4 | 2021 | 448 | 0.460 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 413 | 0.440 |
Why?
| | Amniotic Fluid | 5 | 2022 | 64 | 0.440 |
Why?
| | Nitric Oxide | 7 | 2011 | 823 | 0.440 |
Why?
| | Nitric Oxide Synthase | 3 | 2006 | 209 | 0.440 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2014 | 157 | 0.430 |
Why?
| | Premature Birth | 4 | 2023 | 276 | 0.420 |
Why?
| | Puerperal Disorders | 2 | 2008 | 30 | 0.420 |
Why?
| | Laser-Doppler Flowmetry | 3 | 2005 | 32 | 0.410 |
Why?
| | Pulsatile Flow | 7 | 2011 | 54 | 0.400 |
Why?
| | Blood Pressure | 4 | 2017 | 1538 | 0.390 |
Why?
| | NFATC Transcription Factors | 1 | 2012 | 78 | 0.380 |
Why?
| | Apoptosis | 5 | 2017 | 2363 | 0.370 |
Why?
| | Iron-Dextran Complex | 2 | 2003 | 9 | 0.370 |
Why?
| | Organ Size | 11 | 2015 | 436 | 0.360 |
Why?
| | Biometry | 2 | 2008 | 62 | 0.360 |
Why?
| | Hemodynamics | 8 | 2009 | 1012 | 0.350 |
Why?
| | Gastroschisis | 2 | 2020 | 15 | 0.340 |
Why?
| | Fetal Therapies | 3 | 2019 | 30 | 0.340 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2009 | 33 | 0.340 |
Why?
| | Caspase 3 | 1 | 2010 | 235 | 0.330 |
Why?
| | Pregnancy Reduction, Multifetal | 2 | 2021 | 5 | 0.330 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2011 | 398 | 0.330 |
Why?
| | Lung | 12 | 2023 | 3561 | 0.320 |
Why?
| | Retrospective Studies | 17 | 2023 | 12558 | 0.320 |
Why?
| | Polycythemia | 2 | 2021 | 23 | 0.320 |
Why?
| | Amino Acids, Essential | 1 | 2008 | 12 | 0.320 |
Why?
| | Hydrocephalus | 2 | 2022 | 83 | 0.310 |
Why?
| | Heart Rate | 2 | 2012 | 709 | 0.310 |
Why?
| | Animals | 38 | 2021 | 31710 | 0.310 |
Why?
| | Nutritional Status | 1 | 2010 | 287 | 0.300 |
Why?
| | Iliac Vein | 1 | 2008 | 8 | 0.300 |
Why?
| | Femoral Vein | 1 | 2008 | 28 | 0.290 |
Why?
| | Twins, Monozygotic | 2 | 2021 | 210 | 0.290 |
Why?
| | Iliac Artery | 1 | 2008 | 43 | 0.290 |
Why?
| | Papio | 5 | 2021 | 96 | 0.290 |
Why?
| | Amniocentesis | 3 | 2019 | 21 | 0.290 |
Why?
| | Prenatal Diagnosis | 3 | 2017 | 167 | 0.290 |
Why?
| | Dystocia | 1 | 2007 | 9 | 0.290 |
Why?
| | Protein Kinases | 1 | 2009 | 307 | 0.290 |
Why?
| | Venous Thrombosis | 1 | 2008 | 140 | 0.260 |
Why?
| | Polyhydramnios | 2 | 2023 | 17 | 0.260 |
Why?
| | Transcription Factors | 2 | 2014 | 1528 | 0.260 |
Why?
| | Airway Obstruction | 2 | 2020 | 168 | 0.250 |
Why?
| | Fellowships and Scholarships | 2 | 2018 | 227 | 0.250 |
Why?
| | Fetoscopy | 3 | 2022 | 28 | 0.240 |
Why?
| | Trophoblasts | 4 | 2015 | 165 | 0.240 |
Why?
| | RNA, Messenger | 7 | 2012 | 2553 | 0.230 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 299 | 0.230 |
Why?
| | Bartter Syndrome | 1 | 2023 | 7 | 0.220 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2004 | 64 | 0.220 |
Why?
| | Adult | 23 | 2021 | 30562 | 0.220 |
Why?
| | Asphyxia | 1 | 2003 | 21 | 0.220 |
Why?
| | Prenatal Care | 4 | 2022 | 253 | 0.220 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 17 | 0.220 |
Why?
| | Pregnancy Trimester, Third | 4 | 2020 | 79 | 0.220 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 90 | 0.210 |
Why?
| | Pregnancy Proteins | 2 | 2015 | 36 | 0.210 |
Why?
| | Fever | 5 | 2009 | 280 | 0.210 |
Why?
| | Models, Animal | 3 | 2012 | 344 | 0.210 |
Why?
| | Hot Temperature | 3 | 2014 | 302 | 0.210 |
Why?
| | Osmolar Concentration | 3 | 2014 | 173 | 0.210 |
Why?
| | Infant | 8 | 2023 | 7969 | 0.200 |
Why?
| | Aspirin | 2 | 2015 | 324 | 0.200 |
Why?
| | Pulmonary Surfactants | 2 | 1993 | 99 | 0.200 |
Why?
| | Uterine Cervical Diseases | 1 | 2022 | 6 | 0.200 |
Why?
| | Fetal Monitoring | 1 | 2002 | 16 | 0.200 |
Why?
| | Blood Circulation | 1 | 2002 | 36 | 0.200 |
Why?
| | Blood Vessels | 2 | 2000 | 180 | 0.200 |
Why?
| | Meconium | 1 | 2001 | 7 | 0.190 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2001 | 11 | 0.190 |
Why?
| | Cervix Uteri | 1 | 2022 | 45 | 0.190 |
Why?
| | Diet, Protein-Restricted | 1 | 2021 | 10 | 0.190 |
Why?
| | Rheology | 1 | 2022 | 86 | 0.190 |
Why?
| | Emergencies | 1 | 2022 | 146 | 0.190 |
Why?
| | Amino Acid Transport System L | 1 | 2021 | 16 | 0.190 |
Why?
| | Nasopharynx | 1 | 2001 | 61 | 0.190 |
Why?
| | Sensitivity and Specificity | 6 | 2015 | 1695 | 0.190 |
Why?
| | Amino Acid Transport System A | 1 | 2021 | 33 | 0.180 |
Why?
| | Prospective Studies | 7 | 2022 | 6220 | 0.180 |
Why?
| | Retrognathia | 1 | 2020 | 4 | 0.180 |
Why?
| | Fetal Death | 3 | 2023 | 50 | 0.180 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 219 | 0.180 |
Why?
| | Micrognathism | 1 | 2020 | 10 | 0.180 |
Why?
| | Risk Factors | 8 | 2021 | 8634 | 0.180 |
Why?
| | Heart Diseases | 1 | 2004 | 331 | 0.180 |
Why?
| | Bupivacaine | 1 | 2020 | 31 | 0.180 |
Why?
| | Arm | 2 | 2016 | 104 | 0.180 |
Why?
| | Twins, Dizygotic | 1 | 2021 | 182 | 0.180 |
Why?
| | Myometrium | 2 | 2011 | 35 | 0.170 |
Why?
| | Respiration | 4 | 2006 | 180 | 0.170 |
Why?
| | Anesthetics, Local | 1 | 2020 | 81 | 0.170 |
Why?
| | Ductus Arteriosus | 3 | 2018 | 67 | 0.170 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 847 | 0.170 |
Why?
| | Anemia | 1 | 2021 | 143 | 0.170 |
Why?
| | Goats | 1 | 1999 | 26 | 0.170 |
Why?
| | Respiratory Distress Syndrome, Newborn | 3 | 1999 | 101 | 0.170 |
Why?
| | Leg | 2 | 2016 | 225 | 0.170 |
Why?
| | Umbilical Cord | 4 | 2010 | 80 | 0.160 |
Why?
| | Obstetric Surgical Procedures | 1 | 2019 | 5 | 0.160 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2022 | 241 | 0.160 |
Why?
| | Case-Control Studies | 5 | 2021 | 3004 | 0.160 |
Why?
| | Reference Values | 4 | 2008 | 743 | 0.160 |
Why?
| | Pregnancy Trimester, Second | 3 | 2017 | 66 | 0.160 |
Why?
| | Pain, Postoperative | 1 | 2020 | 191 | 0.160 |
Why?
| | Maternal Health | 1 | 2019 | 42 | 0.160 |
Why?
| | Colorado | 7 | 2020 | 4100 | 0.160 |
Why?
| | Tocolytic Agents | 1 | 2018 | 15 | 0.160 |
Why?
| | Time Factors | 7 | 2019 | 6114 | 0.150 |
Why?
| | Maternal Exposure | 1 | 2020 | 138 | 0.150 |
Why?
| | Indomethacin | 1 | 2018 | 70 | 0.150 |
Why?
| | Immunohistochemistry | 3 | 2010 | 1629 | 0.150 |
Why?
| | Biological Transport | 3 | 2021 | 374 | 0.150 |
Why?
| | Cardiomyopathies | 1 | 2021 | 298 | 0.150 |
Why?
| | Hyaline Membrane Disease | 2 | 1997 | 20 | 0.150 |
Why?
| | Hysterotomy | 1 | 2017 | 10 | 0.150 |
Why?
| | Body Mass Index | 3 | 2019 | 1959 | 0.150 |
Why?
| | Antibiotic Prophylaxis | 2 | 2011 | 96 | 0.140 |
Why?
| | Duodenal Obstruction | 1 | 2017 | 5 | 0.140 |
Why?
| | Esophageal Atresia | 1 | 2017 | 26 | 0.140 |
Why?
| | Hypertension | 1 | 2005 | 1056 | 0.140 |
Why?
| | Paralysis | 1 | 1997 | 66 | 0.140 |
Why?
| | Embryonic and Fetal Development | 4 | 2001 | 94 | 0.140 |
Why?
| | Attitude | 1 | 2018 | 229 | 0.130 |
Why?
| | Comorbidity | 1 | 2021 | 1448 | 0.130 |
Why?
| | Curriculum | 1 | 2022 | 819 | 0.130 |
Why?
| | Lateral Ventricles | 1 | 2016 | 24 | 0.130 |
Why?
| | Placental Circulation | 3 | 2012 | 56 | 0.130 |
Why?
| | Intracranial Embolism and Thrombosis | 1 | 1995 | 6 | 0.130 |
Why?
| | Protein S Deficiency | 1 | 1995 | 6 | 0.130 |
Why?
| | Caspases | 1 | 2017 | 245 | 0.130 |
Why?
| | Hypertension, Pulmonary | 3 | 2022 | 1729 | 0.130 |
Why?
| | Aldehyde Reductase | 2 | 2014 | 24 | 0.130 |
Why?
| | Blotting, Western | 4 | 2011 | 1147 | 0.130 |
Why?
| | Symporters | 2 | 2014 | 52 | 0.130 |
Why?
| | Fetal Blood | 3 | 2008 | 270 | 0.130 |
Why?
| | Mannose | 2 | 2012 | 21 | 0.120 |
Why?
| | Fetal Heart | 1 | 2015 | 37 | 0.120 |
Why?
| | Young Adult | 6 | 2021 | 10472 | 0.120 |
Why?
| | Cohort Studies | 4 | 2020 | 4895 | 0.120 |
Why?
| | MicroRNAs | 1 | 2021 | 600 | 0.120 |
Why?
| | Coronary Circulation | 1 | 2015 | 133 | 0.120 |
Why?
| | Choriocarcinoma | 1 | 2014 | 8 | 0.120 |
Why?
| | Metformin | 1 | 2018 | 276 | 0.120 |
Why?
| | Pilot Projects | 3 | 2020 | 1373 | 0.120 |
Why?
| | Calcium | 2 | 2011 | 1108 | 0.120 |
Why?
| | Regression Analysis | 3 | 2008 | 945 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2014 | 53 | 0.120 |
Why?
| | Caloric Restriction | 1 | 2015 | 90 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 281 | 0.110 |
Why?
| | Sheep Diseases | 1 | 2014 | 7 | 0.110 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2014 | 11 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 4 | 2023 | 3053 | 0.110 |
Why?
| | Ultrasonography | 2 | 2022 | 634 | 0.110 |
Why?
| | Down-Regulation | 3 | 2021 | 594 | 0.110 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 6 | 0.110 |
Why?
| | Uterine Neoplasms | 1 | 2014 | 73 | 0.110 |
Why?
| | Longitudinal Studies | 3 | 2013 | 2387 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 771 | 0.110 |
Why?
| | Body Weights and Measures | 1 | 2013 | 34 | 0.110 |
Why?
| | Femur | 3 | 2008 | 191 | 0.110 |
Why?
| | Coronary Vessels | 1 | 2015 | 227 | 0.110 |
Why?
| | Umbilicus | 1 | 2013 | 14 | 0.110 |
Why?
| | Signal Transduction | 4 | 2011 | 4517 | 0.110 |
Why?
| | Rabbits | 3 | 2003 | 733 | 0.110 |
Why?
| | Fatty Alcohols | 1 | 1992 | 5 | 0.100 |
Why?
| | Phosphorylcholine | 1 | 1992 | 17 | 0.100 |
Why?
| | Amnion | 1 | 1992 | 24 | 0.100 |
Why?
| | Lung Volume Measurements | 2 | 2023 | 45 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2001 | 1473 | 0.100 |
Why?
| | Calcium Signaling | 2 | 2011 | 217 | 0.100 |
Why?
| | NADP | 1 | 2012 | 43 | 0.100 |
Why?
| | Estradiol | 3 | 2000 | 455 | 0.100 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1394 | 0.100 |
Why?
| | Animals, Newborn | 5 | 2000 | 778 | 0.100 |
Why?
| | Isotope Labeling | 1 | 2012 | 69 | 0.100 |
Why?
| | Clinical Competence | 1 | 2018 | 893 | 0.090 |
Why?
| | Abdomen | 2 | 2003 | 99 | 0.090 |
Why?
| | Cesarean Section | 2 | 2012 | 169 | 0.090 |
Why?
| | Blood Volume | 1 | 2011 | 59 | 0.090 |
Why?
| | Pregnancy Trimesters | 1 | 2010 | 13 | 0.090 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2010 | 14 | 0.090 |
Why?
| | Keratin-18 | 1 | 2010 | 10 | 0.090 |
Why?
| | Chorionic Villi | 1 | 2010 | 16 | 0.090 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1012 | 0.090 |
Why?
| | Galectins | 1 | 2010 | 22 | 0.090 |
Why?
| | Probability | 2 | 2001 | 289 | 0.090 |
Why?
| | Infant, Premature | 2 | 2012 | 476 | 0.090 |
Why?
| | Oxygen | 4 | 2008 | 854 | 0.090 |
Why?
| | Carbohydrate Metabolism | 1 | 2010 | 48 | 0.090 |
Why?
| | Calcium Channels | 1 | 2011 | 145 | 0.090 |
Why?
| | Carbohydrates | 1 | 2010 | 55 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 2011 | 221 | 0.090 |
Why?
| | Term Birth | 1 | 2009 | 19 | 0.080 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2009 | 11 | 0.080 |
Why?
| | TRPC Cation Channels | 1 | 2009 | 11 | 0.080 |
Why?
| | Biomarkers | 3 | 2021 | 3408 | 0.080 |
Why?
| | Diglycerides | 1 | 2009 | 53 | 0.080 |
Why?
| | Hyperthermia, Induced | 1 | 2010 | 65 | 0.080 |
Why?
| | High-Frequency Ventilation | 2 | 1999 | 41 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 234 | 0.080 |
Why?
| | Middle Cerebral Artery | 1 | 2009 | 37 | 0.080 |
Why?
| | Cordocentesis | 1 | 2008 | 1 | 0.080 |
Why?
| | Angiography | 1 | 2009 | 174 | 0.080 |
Why?
| | Crown-Rump Length | 1 | 2008 | 3 | 0.080 |
Why?
| | Endothelin-1 | 2 | 2008 | 168 | 0.080 |
Why?
| | Placenta Diseases | 1 | 2008 | 13 | 0.070 |
Why?
| | Blood Gas Analysis | 1 | 2008 | 72 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 1992 | 561 | 0.070 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 28 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2010 | 801 | 0.070 |
Why?
| | Fluorocarbons | 2 | 1999 | 94 | 0.070 |
Why?
| | Birth Injuries | 1 | 2007 | 11 | 0.070 |
Why?
| | Foot | 1 | 2008 | 103 | 0.070 |
Why?
| | Syndrome | 1 | 2008 | 333 | 0.070 |
Why?
| | Pulmonary Circulation | 2 | 2000 | 407 | 0.070 |
Why?
| | Shoulder | 1 | 2007 | 85 | 0.070 |
Why?
| | Body Weight | 3 | 2006 | 869 | 0.070 |
Why?
| | Obesity | 1 | 2019 | 2508 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2009 | 360 | 0.070 |
Why?
| | Polymers | 1 | 2010 | 448 | 0.070 |
Why?
| | Risk | 1 | 2009 | 812 | 0.070 |
Why?
| | Sheep, Domestic | 1 | 2006 | 33 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 1 | 2009 | 512 | 0.070 |
Why?
| | Glucose Transporter Type 4 | 1 | 2006 | 36 | 0.070 |
Why?
| | Vasodilation | 2 | 2000 | 419 | 0.060 |
Why?
| | Fetal Hypoxia | 1 | 2006 | 47 | 0.060 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 42 | 0.060 |
Why?
| | Models, Theoretical | 1 | 2009 | 515 | 0.060 |
Why?
| | Echocardiography | 2 | 2021 | 553 | 0.060 |
Why?
| | Infant, Premature, Diseases | 1 | 2007 | 89 | 0.060 |
Why?
| | Biophysics | 1 | 2006 | 69 | 0.060 |
Why?
| | Labor, Obstetric | 1 | 2004 | 52 | 0.060 |
Why?
| | Self Report | 2 | 2018 | 696 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2014 | 3886 | 0.060 |
Why?
| | Body Size | 1 | 2004 | 92 | 0.060 |
Why?
| | Potassium Chloride | 1 | 2003 | 32 | 0.060 |
Why?
| | Heat-Shock Proteins | 2 | 2014 | 113 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 498 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 808 | 0.050 |
Why?
| | Fetal Movement | 2 | 2006 | 6 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2004 | 126 | 0.050 |
Why?
| | Brain Diseases | 1 | 2004 | 125 | 0.050 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 103 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 2 | 2014 | 119 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 280 | 0.050 |
Why?
| | Cerebral Palsy | 1 | 2004 | 80 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 222 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2019 | 9089 | 0.050 |
Why?
| | Receptors, Growth Factor | 1 | 2002 | 49 | 0.050 |
Why?
| | Laparoscopy | 2 | 1997 | 398 | 0.050 |
Why?
| | Face | 1 | 2003 | 164 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 50 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1470 | 0.050 |
Why?
| | Apgar Score | 1 | 2001 | 16 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 111 | 0.050 |
Why?
| | Bone and Bones | 1 | 2004 | 279 | 0.050 |
Why?
| | Perineum | 1 | 2001 | 25 | 0.050 |
Why?
| | Constriction | 2 | 2018 | 45 | 0.050 |
Why?
| | Light Coagulation | 1 | 2021 | 7 | 0.050 |
Why?
| | Italy | 1 | 2001 | 92 | 0.050 |
Why?
| | Suction | 1 | 2001 | 31 | 0.050 |
Why?
| | Endpoint Determination | 1 | 2001 | 68 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 355 | 0.050 |
Why?
| | Protein Biosynthesis | 1 | 2003 | 387 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 367 | 0.050 |
Why?
| | Myocardium | 1 | 2006 | 913 | 0.050 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 1796 | 0.050 |
Why?
| | Drainage | 1 | 2021 | 151 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2003 | 588 | 0.040 |
Why?
| | Gastrostomy | 1 | 2021 | 91 | 0.040 |
Why?
| | Male | 6 | 2012 | 55669 | 0.040 |
Why?
| | Airway Management | 1 | 2020 | 60 | 0.040 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2021 | 141 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2021 | 455 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 124 | 0.040 |
Why?
| | Insulin | 2 | 2006 | 2082 | 0.040 |
Why?
| | Maternal Age | 1 | 2020 | 117 | 0.040 |
Why?
| | Parietal Bone | 1 | 1999 | 11 | 0.040 |
Why?
| | Diffusion | 1 | 1999 | 119 | 0.040 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1016 | 0.040 |
Why?
| | Perinatal Death | 1 | 2019 | 22 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2019 | 31 | 0.040 |
Why?
| | Arteries | 1 | 2000 | 247 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 74 | 0.040 |
Why?
| | Anthropometry | 1 | 1999 | 183 | 0.040 |
Why?
| | Linear Models | 2 | 2017 | 768 | 0.040 |
Why?
| | Phosphorylation | 2 | 2014 | 1569 | 0.040 |
Why?
| | Respiration, Artificial | 2 | 1999 | 529 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 923 | 0.040 |
Why?
| | Survival Rate | 1 | 2022 | 1644 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2017 | 4411 | 0.040 |
Why?
| | Enteral Nutrition | 1 | 2019 | 160 | 0.040 |
Why?
| | Pancuronium | 1 | 1997 | 3 | 0.040 |
Why?
| | Tibia | 1 | 1999 | 166 | 0.040 |
Why?
| | Neuromuscular Depolarizing Agents | 1 | 1997 | 4 | 0.040 |
Why?
| | Bronchodilator Agents | 1 | 1999 | 239 | 0.040 |
Why?
| | Obstetric Labor, Premature | 1 | 1997 | 33 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 1842 | 0.040 |
Why?
| | Intestinal Atresia | 1 | 2017 | 16 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 1998 | 385 | 0.030 |
Why?
| | Length of Stay | 1 | 2001 | 962 | 0.030 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1997 | 58 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 1997 | 116 | 0.030 |
Why?
| | United States | 3 | 2018 | 12184 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2004 | 4411 | 0.030 |
Why?
| | Pulmonary Edema | 1 | 1997 | 115 | 0.030 |
Why?
| | Genetic Counseling | 1 | 2017 | 65 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1214 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1997 | 139 | 0.030 |
Why?
| | Administration, Inhalation | 4 | 1999 | 641 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 122 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 908 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 1997 | 239 | 0.030 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.030 |
Why?
| | Insufflation | 1 | 1995 | 9 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2015 | 71 | 0.030 |
Why?
| | Transport Vesicles | 1 | 2015 | 18 | 0.030 |
Why?
| | Carbon Dioxide | 2 | 1995 | 218 | 0.030 |
Why?
| | Placenta Growth Factor | 1 | 2015 | 22 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2000 | 1226 | 0.030 |
Why?
| | Twins | 1 | 2017 | 240 | 0.030 |
Why?
| | Aorta | 1 | 1998 | 386 | 0.030 |
Why?
| | Genetic Therapy | 1 | 1997 | 257 | 0.030 |
Why?
| | Saimiri | 1 | 1995 | 6 | 0.030 |
Why?
| | Neutrophils | 2 | 1999 | 1176 | 0.030 |
Why?
| | Uterine Prolapse | 1 | 1995 | 11 | 0.030 |
Why?
| | Urethral Diseases | 1 | 1995 | 18 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 664 | 0.030 |
Why?
| | DNA Fragmentation | 1 | 2014 | 47 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 722 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2540 | 0.030 |
Why?
| | Pregnancy in Diabetics | 1 | 1995 | 82 | 0.030 |
Why?
| | Program Evaluation | 1 | 2018 | 822 | 0.030 |
Why?
| | Thoracotomy | 1 | 2013 | 75 | 0.030 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 4624 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1430 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 2014 | 157 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1016 | 0.030 |
Why?
| | Registries | 1 | 2020 | 1768 | 0.030 |
Why?
| | Hydrogen | 1 | 2012 | 59 | 0.020 |
Why?
| | Injections | 1 | 1992 | 163 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 1841 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 1993 | 522 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 111 | 0.020 |
Why?
| | Drug Combinations | 1 | 1992 | 287 | 0.020 |
Why?
| | Heart Rate, Fetal | 2 | 2006 | 20 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 1997 | 520 | 0.020 |
Why?
| | Anticoagulants | 1 | 1995 | 550 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 1660 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 812 | 0.020 |
Why?
| | Myo-Inositol-1-Phosphate Synthase | 1 | 2010 | 2 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 146 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 171 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 164 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 2968 | 0.020 |
Why?
| | TRPC6 Cation Channel | 1 | 2009 | 1 | 0.020 |
Why?
| | Fructose | 1 | 2010 | 100 | 0.020 |
Why?
| | Intracellular Space | 1 | 2009 | 68 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 194 | 0.020 |
Why?
| | Efficiency | 1 | 2009 | 84 | 0.020 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2008 | 6 | 0.020 |
Why?
| | Sodium | 1 | 2009 | 183 | 0.020 |
Why?
| | Adolescent | 3 | 2017 | 17856 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2128 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 2 | 1999 | 117 | 0.020 |
Why?
| | Head | 1 | 2008 | 85 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 535 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2009 | 343 | 0.020 |
Why?
| | Partial Pressure | 1 | 2006 | 30 | 0.020 |
Why?
| | Heating | 1 | 2006 | 17 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 270 | 0.020 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2006 | 56 | 0.020 |
Why?
| | Glycogen | 1 | 2006 | 51 | 0.020 |
Why?
| | Forecasting | 1 | 2008 | 330 | 0.020 |
Why?
| | Liver | 2 | 2010 | 1637 | 0.020 |
Why?
| | Receptor, Insulin | 1 | 2006 | 93 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1421 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2011 | 687 | 0.020 |
Why?
| | Body Temperature | 1 | 2006 | 208 | 0.020 |
Why?
| | Lactic Acid | 1 | 2006 | 275 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 723 | 0.010 |
Why?
| | Hospitals, University | 1 | 2004 | 172 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 329 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2006 | 298 | 0.010 |
Why?
| | Nuclease Protection Assays | 1 | 2003 | 5 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 388 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2004 | 187 | 0.010 |
Why?
| | Drinking | 1 | 2003 | 33 | 0.010 |
Why?
| | Acid-Base Equilibrium | 1 | 2003 | 29 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2003 | 193 | 0.010 |
Why?
| | Respiratory Mechanics | 1 | 2003 | 56 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 86 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 66 | 0.010 |
Why?
| | Child | 2 | 2020 | 18423 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2320 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 61 | 0.010 |
Why?
| | Glucose | 1 | 2006 | 897 | 0.010 |
Why?
| | Species Specificity | 1 | 2002 | 542 | 0.010 |
Why?
| | Ligation | 1 | 2000 | 75 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2000 | 77 | 0.010 |
Why?
| | Hydrocarbons, Brominated | 1 | 1999 | 5 | 0.010 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2000 | 141 | 0.010 |
Why?
| | Muscle, Smooth | 1 | 2000 | 144 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1995 | 3256 | 0.010 |
Why?
| | Blood Glucose | 1 | 2006 | 1828 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1997 | 60 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1997 | 161 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1997 | 293 | 0.010 |
Why?
| | Cardiomegaly | 1 | 1997 | 157 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2002 | 1019 | 0.010 |
Why?
| | Postoperative Period | 1 | 1997 | 289 | 0.010 |
Why?
| | Acidosis, Respiratory | 1 | 1995 | 3 | 0.010 |
Why?
| | Catheterization, Swan-Ganz | 1 | 1995 | 8 | 0.010 |
Why?
| | Central Venous Pressure | 1 | 1995 | 12 | 0.010 |
Why?
| | Anesthesia, General | 1 | 1995 | 44 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1997 | 253 | 0.010 |
Why?
| | General Surgery | 1 | 1997 | 127 | 0.010 |
Why?
| | Pulmonary Wedge Pressure | 1 | 1995 | 63 | 0.010 |
Why?
| | Prolapse | 1 | 1995 | 5 | 0.010 |
Why?
| | Tidal Volume | 1 | 1995 | 75 | 0.010 |
Why?
| | Vasodilator Agents | 1 | 1997 | 302 | 0.010 |
Why?
| | Cardiac Output | 1 | 1995 | 143 | 0.010 |
Why?
| | Vulva | 1 | 1995 | 24 | 0.010 |
Why?
| | Safety | 1 | 1997 | 298 | 0.010 |
Why?
| | Pressure | 1 | 1995 | 214 | 0.010 |
Why?
| | Catheterization, Peripheral | 1 | 1995 | 101 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1995 | 337 | 0.010 |
Why?
| | Vagina | 1 | 1995 | 146 | 0.010 |
Why?
| | Databases, Factual | 1 | 1997 | 1126 | 0.010 |
Why?
| | Oxazoles | 1 | 1971 | 29 | 0.010 |
Why?
| | Penicillins | 1 | 1971 | 52 | 0.010 |
Why?
| | Chronic Disease | 1 | 1997 | 1579 | 0.010 |
Why?
| | Leukocytes | 1 | 1971 | 276 | 0.010 |
Why?
| | Respiratory Tract Infections | 1 | 1971 | 319 | 0.000 |
Why?
| | Middle Aged | 1 | 2006 | 26740 | 0.000 |
Why?
| | Kidney | 1 | 1971 | 1188 | 0.000 |
Why?
| | Dicloxacillin | 1 | 1971 | 1 | 0.000 |
Why?
| | Evaluation Studies as Topic | 1 | 1971 | 167 | 0.000 |
Why?
| | Imidazoles | 1 | 1971 | 208 | 0.000 |
Why?
| | Administration, Oral | 1 | 1971 | 729 | 0.000 |
Why?
| | Child, Preschool | 1 | 1971 | 9119 | 0.000 |
Why?
|
|
Galan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|